Biosimilar Etanercept Use in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: The RHUMADATA® Registry Experience

被引：0
|
作者：
Moura, Cristiano S. [1 ]
Choquette, Denis [2 ]
Coupal, Louis [3 ]
Bessette, Louis [4 ]
Bernatsky, Sasha [5 ]
机构：
[1] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[2] Univ Montreal, Inst Rech Rhumatol Montreal, Montreal, PQ, Canada
[3] Inst Rech Rhumatol Montreal, Montreal, PQ, Canada
[4] Laval Univ, Quebec City, PQ, Canada
[5] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1080
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Infliximab Biosimilar use in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients: The RHUMADATA Registry Experience
    Moura, Cristiano
    Choquette, Denis
    Coupal, Louis
    Bessette, Louis
    Bernatsky, Sasha
    [J]. JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 819 - 819
  • [2] Biosimilar Etanercept Use in Rheumatoid Arthritis: The Rhumadata Registry Experience
    Moura, Cristiano
    Bernatsky, Sasha
    Coupal, Louis
    Bessette, Louis
    Choquette, Denis
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1107 - 1107
  • [3] ETANERCEPT RETENTION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS
    Dongen, C. V.
    Kneepkens, E.
    Vogelzang, E.
    l'Ami, M.
    Krieckaert, C.
    van der Horst, I.
    Voskuyl, A.
    Nurmohamed, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1145 - 1145
  • [4] Patient Satisfaction and Experience with Golimumab, Adalimumab, and Etanercept for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Bolge, Susan
    Eldridge, Helen
    Doshi, Dilesh
    Ellis, Lorie
    Roland, Barbara
    Woelfel, John
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S817 - S817
  • [5] Risk: Benefit Profile of Etanercept in Elderly Patients with Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis
    Roy Fleischmann
    Imran Iqbal
    [J]. Drugs & Aging, 2007, 24 : 239 - 254
  • [6] Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial
    Ruwaard, J.
    Ami, M. J. L'
    Kneepkens, E. L.
    Krieckaert, C. L. M.
    Nurmohamed, M. T.
    Hooijberg, F.
    van Kuijk, A. W. R.
    van Denderen, J. C.
    Burgemeister, L.
    Rispens, T.
    Boers, M.
    Wolbink, G. J.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 (02) : 129 - 136
  • [7] Risk: Benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis
    Fleischmann, Roy
    Iqbal, Imran
    [J]. DRUGS & AGING, 2007, 24 (03) : 239 - 254
  • [8] Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
    Sacchi, Viola
    Zaniolo, Orietta
    Olivieri, Ignazio
    [J]. FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2010, 11 (02) : 63 - 76
  • [9] Etanercept - A review of its use in the management of ankylosing spondylitis and psoriatic arthritis
    Hoy, Sheridan M.
    Scott, Lesley J.
    [J]. DRUGS, 2007, 67 (17) : 2609 - 2633
  • [10] Golimumab: a guide to its use in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    [J]. Drugs & Therapy Perspectives, 2010, 26 (4) : 1 - 4
12345